FDA
-
-
-
-
-
-
-
Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer
-
-
-
-
-
-
-
On National Viagra Day, Women Finally Claim Their Turn:
-
-
-
-
-
-
-
Daré Bioscience launches sildenafil cream for women's arousal
-
-
-
-
-
-
-
Daré Bioscience Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil Cream
-
-
-
-
-
-
-
Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application P
-
-
-
-
-
-
-
Daré Bioscience to Present at the Jones Healthcare and Technology Innovation Conference on Expanded Business Strategy Including Action to Make its Proprietary Sildenafil Cream Formulation Available v
-
324,765 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All
